Daily BriefsHealthcare

Daily Brief Health Care: Duality Biotherapeutics and more

In today’s briefing:

  • China Healthcare Weekly (Sep.28) – Trump’s Pharma Tariff, Companies Increase Their Holdings, Duality


China Healthcare Weekly (Sep.28) – Trump’s Pharma Tariff, Companies Increase Their Holdings, Duality

By Xinyao (Criss) Wang

  • Trump said he will place import taxes on 100% of pharmaceutical drugs, which will begin on Oct.1. Below, we shared our views on this new policy.
  • Some companies continue to repurchase/increase their holdings despite the industry’s significant rise this year, indicating that major shareholders truly have confidence in the outlook. We specifically listed these companies.
  • The fluctuations in Duality’s stock price are obviously driven by capital after being included in HK Stock Connect. we suggest that investors pay attention to risks as Duality faces correction.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars